Marta Brambilla

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Venues

Tumori

JCO precision oncology

Disease markers

Exploration of targeted anti-tumor therapy

Fondazione IRCCS Istituto Nazionale dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fondazione IRCCS Istituto Nazionale dei Tumori Nov 01 2017

Italy

Resident :: Medical Oncology

Ospedale Santa Maria della Misericordia Nov 01 2015 - Oct 30 2017

Italy

Resident :: Medical Oncology

Publications

Jacopo Azzollini, Iolanda Capone, Matteo Duca, Andrea Vingiani, Alberta Piccolo, Luca Agnelli, Elena Tamborini, Federica Perrone, Bernard Peissel, Daniele Lorenzini, Silvia Damian, Claudio Vernieri, Giulia Valeria Bianchi, Mara Mantiero, Monika Ducceschi, Maggie Polignano, Monica Niger, Federico Nichetti, Claudia Proto, Marta Brambilla, Elena Colombo, Marco Stellato, Elena Conca, Adele Busico, Siranoush Manoukian
Is tumour sequencing effective for the identification of germline BRCA1/2 pathogenic variant carriers? Tumori (2024)
Rita Leporati, Daniela Miliziano, Teresa Beninato, Laura Mazzeo, Sara Manglaviti, Marta Brambilla, Mario Alberto Occhipinti, Arsela Prelaj, Claudia Proto, Giuseppe Lo Russo
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs. Tumori (2024)
Andrea Vingiani, Luca Agnelli, Matteo Duca, Daniele Lorenzini, Silvia Damian, Claudia Proto, Monica Niger, Federico Nichetti, Elena Tamborini, Federica Perrone, Alberta Piccolo, Siranoush Manoukian, Jacopo Azzollini, Marta Brambilla, Elena Colombo, Salvatore Lopez, Claudio Vernieri, Francesca Marra, Elena Conca, Adele Busico, Iolanda Capone, Fabio Bozzi, Marta Angelini, Andrea Devecchi, Rebecca Salvatori, Valentina De Micheli, Anna Baggi, Silvia Pasini, Claudio Jommi, Vito Ladisa, Giovanni Apolone, Filippo De Braud, Giancarlo Pruneri
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient Care. JCO precision oncology 7 (2023)
Caterina Zanella, Alberto Giovanni Leone, Luca Zambelli, Achille Bottiglieri, Luca Canziani, Marta Brambilla, Giuseppe Lo Russo, Marco Platania, Filippo De Braud, Mario Alberto Occhipinti
Paraneoplastic neurological syndromes in patients affected by SCLC: a case series. Tumori 108 (6) (2022)
Andrea Spagnoletti, Marco Platania, Marta Brambilla, Mario Alberto Occhipinti, Luca Canziani, Antonello Cabras, Leonardo Provenzano, Alberto Giovanni Leone, Paolo Ambrosini, Arsela Prelaj
Systemic lupus erythematosus reactivation after chemoimmunotherapy in preexisting autoimmune disease. Tumori 108 (6) (2022)
Giuseppe Viscardi, Davide Di Natale, Morena Fasano, Marta Brambilla, Riccardo Lobefaro, Alessandro De Toma, Giulia Galli
Circulating biomarkers in malignant pleural mesothelioma. Exploration of targeted anti-tumor therapy 1 (6) (2020)
Francesca Corti, Marta Brambilla, Sara Manglaviti, Laura Di Vico, Maria Neve Pisanu, Claudia Facchinetti, Katia Fiorella Dotti, Rodolfo Lanocita, Alfonso Marchianò, Filippo de Braud, Laura Anna Maria Ferrari
Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis. Tumori 107 (1) (2020)
Biagio Ricciuti, Giulia C Leonardi, Marta Brambilla
Emerging Biomarkers in the Era of Personalized Cancer Medicine. Disease markers 2019 (2019)

Marta Brambilla.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marta Brambilla